Steroids and NSAIDs in drop form are used by cataract surgeons to reduce inflammation and pain after cataract and other ocular surgery. In the most common study protocol used for FDA approval in the United States, both pain and inflammation are graded …
Author: Healio ophthalmology
New drugs, protocols reduce pain and inflammation associated with cataract surgery
Drugs, better surgical techniques and new technologies can limit the amount of pain and inflammation a patient experiences after undergoing cataract surgery.Ophthalmologists and patients have different views about what constitutes a successful cataract…
Presenting ‘premium’ pricing to the patient: A package deal or a la carte
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.As cataract surgery technology has gained unpre…
Managing IOP issues after cataract surgery
It is recognized that cataract surgery can help lower IOP, likely due to the increased angle opening permitted by the thin IOL as compared with the much thicker cataractous lens. But there can be fluctuations in the IOP after cataract surgery, and thes…
Intraoperative floppy iris syndrome may be possible after DMEK
Intraoperative floppy iris syndrome is a well-known and highly feared entity. By some measures, it is the most common difficulty encountered during cataract surgery and a significant risk factor for severe intraoperative complications, including poster…
How do you balance cost of postoperative steroids and NSAIDs and still keep pace with innovative medications?
Click here to read the Cover Story to this Point/Counter.For cataract surgery, we use Pred-Gati-Brom (prednisolone acetate, gatifloxacin, bromfenac) from Imprimis. If the patient is upgrading in any way, including limbal relaxing incisions, the drop is…
DREAM: Fish oil works
The jury has returned, and the verdict is in: If you treat dry eye disease with a protocol that includes purified fish oil, your patients will feel better. Seriously. It says so right there in the results section of the DREAM study. Patients with sever…
Gemini to initiate CLARITY dry AMD disease registry and study
Gemini Therapeutics announced a disease registry and natural history study to identify and characterize disease progression in patients with non-central geographic atrophy secondary to dry age-related macular degeneration, according to a press release….
Inveltys now available in US
Kala Pharmaceuticals has launched its twice-daily ocular corticosteroid Inveltys in the United States, according to a press release.Inveltys (loteprednol etabonate ophthalmic suspension 1%), which uses Kala’s Ampplify mucus-penetrating particle drug de…
Netarsudil ophthalmic solution shows positive phase 2 results in Japanese-American population
A pilot phase 2 trial showed Aerie Pharmaceuticals’ netarsudil ophthalmic solution lowered IOP in a Japanese-American population, according to a press release.Two dose concentrations of netarsudil ophthalmic solution, known as Rhopressa (netarsudil oph…
Bimatoprost sustained-release implant reduces IOP in phase 3 study
A bimatoprost sustained-release implant reduced IOP by approximately 30% over 12 weeks in a second phase 3 study, Allergan announced in a press release.The majority of patients with open-angle glaucoma or ocular hypertension in the 528-subject trial we…
VIDEO: State of the art of intracameral antibiotics and steroids: Drop-free cataract surgery
NEW YORK — From OSN New York 2018, M. Stewart Galloway, MD, of Cumberland Eye Care in Crossville, Tennessee, gives his presentation on the state of the art of intracameral antibiotics and steroids.
VIDEO: Presbyopia correction in the post-corneal refractive surgery patient
NEW YORK — From OSN New York 2018, Kathryn M. Hatch, MD, director of refractive surgery at Massachusetts Eye and Ear, gives her presentation on presbyopia correction in the post-corneal refractive surgery patient.
Laser-induced chorioretinal anastomosis can lessen CRVO treatment burden
Adding laser-induced chorioretinal anastomosis to anti-VEGF treatment for central retinal vein occlusion can reduce the number of injections needed, according to a study.A randomized clinical trial included 58 patients with macular edema caused by CRVO…
EyePoint plans accelerated Dexycu launch
EyePoint Pharmaceuticals will launch both Dexycu and Yutiq in the first quarter, the company announced in a press release.The two drugs were approved in 2018, and while the company originally planned to launch Yutiq (fluocinolone acetonide intravitreal…
Oculis completes Series B funding
Oculis has completed an extension of its Series B funding of 15.5 million Swiss francs, bringing the funding round to a total of 35.5 million Swiss francs, according to a press release.Led by Tekla Capital Management, the round also included funding fr…
VIDEO: Blended vision: Still popular
NEW YORK — From OSN New York 2018, Cynthia A. Matossian, MD, founder and CEO of Matossian Eye Associates, gives her presentation on blended vision for the correction of presbyopia.
Sequential epi-on cross-linking, topography-guided PRK show good results
Topography-guided PRK improves vision in keratoconus patients after corneal cross-linking, according to a study published in Journal of Cataract and Refractive Surgery.“Our study is the largest U.S. series investigating the safety and efficacy of these…
Anti-VEGF injections may play increasing role in treatment of diabetic retinopathy
Patients with diabetic macular edema and moderately severe to severe nonproliferative diabetic retinopathy, as determined on the ETDRS Diabetic Retinopathy Severity Scale, greatly benefit from intravitreal anti-VEGF injection with ranibizumab, with mor…
Is there a future for neuroprotection in the treatment of glaucoma?
Click here to view the Cover Story to this Point/Counter.The clinical trial design to test neuroprotection has improved dramatically recently, and we now have convincing clinical evidence that neuroprotection can be the next exciting step into the futu…